Antithrombotic Activity of Sunghyangjunggisan

  • Park, Eun-Kyung (College of Pharmacy, and East-West Research Institute, Kyung Hee University) ;
  • Yoon, Hae-Kyung (Department of Human Life Science, Kyungwon College) ;
  • Kim, Dong-Hyun (College of Pharmacy, and East-West Research Institute, Kyung Hee University,Department of Human Life Science, Kyungwon College)
  • Published : 2002.06.01

Abstract

As apart of our continuing search for antistroke agents from the herbal medicinal resources, we examined in vitro, ex vivo and in vivo the possibility of Sunghyangjunggisan and its ingradients as a novel antithrombotic agent. In vitro ADP- and collagen-induced rat platelet aggregations were potently inhibited by Arisaematis Rhizoma, Cinnamomi Cortex and Zingiberis Rhizoma in a dose-dependent manner, but not by Sunghyangjunggisan. However, Sunghyangjunggisan significantly inhibited ex vivo rat platelet aggregation. Arisaematis Rhizoma, Atractylodis Rhizoma Alba, and Pinelliae Rhizoma also significantly inhibited ex vivo rat platelet aggregation. Sunghyangjunggisan, Alpiniae Fructus and Zingiberis Rhizoma showed significant protection from death due to pulmonary thrombosis in mice. Therefore, Sunghyangjunggisan can express the antithrombotic action, when it is orally administered.

Keywords

References

  1. Bae, C. H., Cho, K. H., Lee, W. C., Kim, Y. S., Bae, H. S., Lee, K. S. and Koo, B. H., 1987. Clinical Analysis of Occlusive Cerebrovascular Disease, Kyung Hee Univ. Orient. Med. J., 10, 665-687
  2. Born, G. V. R., Cross, M. J., 1963. The aggreagation of blood platelet. J. Physiol., 168, 178-195 https://doi.org/10.1113/jphysiol.1963.sp007185
  3. Dinerman, J. L., Mehta, J. L., 1990. Endothelial, Platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J. Am. Coll. Cardiol 16, 207-222 https://doi.org/10.1016/0735-1097(90)90481-4
  4. Di Minno G., Silver, M., 1983. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol., J. Pharmacol. Exp. Ther., 225(1) PP. 57-60
  5. Hara, T., Yokoyama, A., Ishihara, H., Yokoyama, Y, Nagahara, T., Iwanoto, M., 1994. DX-9065a, a new synthedc, Potent anticoagulant and selective inhibitor for factor Xa. Thromb. Haemost., 71, 314-9
  6. Hornstra, G., Christ-Hazelhof, E., Haddeman, E., Ten, H. R., Nugsteren, D.H., 1981. Fish oil feeding lowers thrOmbOXane-and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin $I_3.$ Prostagtandins, 21, 727-38 https://doi.org/10.1016/0090-6980(81)90230-6
  7. Kim, D.-H., Jung, E.-A., Sohng, I.-S., Han, J.-A., Kim, T. H., Han M.J. 1998. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res., 21, 17-23 https://doi.org/10.1007/BF03216747
  8. Kimura, Y., Tani, T., Kanbe, T., Watanabe, K., 1985. Effect of cilostazol on platelet aggregation and expenmental thrombosis., Arzneim., Forsch. Drus Res., 35, 1144-49
  9. Lee, J. M., 1996. Longegity and life Preservation in Oriental Medicine (translated by S.H. Choi) PP. 153-175, Kyung Hee Univ. Press, Seoul
  10. MacMahon, S., Sharpe, N., 1991. Long-term antiplatelet therapy for the prevendon of vascular disease. Med. J. Aust., 154, 477-80
  11. Mustard, .J. F., 1975. Platelets, thrombosis and drugs. Druss 9, 19-76
  12. Mustard J. R, Packham, M. A., Kinlough-Rathbone, R. L., 1990. Platelets, blood flow, and the vessel wall. Circulation 81, 124-7
  13. Packham, M. A., 1994. Role of platelets in thrombosis and hemostasis. Can. J. Physiol. Pharmacol., 72, 278-84 https://doi.org/10.1139/y94-043
  14. Stein B. Fuster, V., 1989. Role of platelet inhibitor therapy in myocardial mfarction. Cardiovasc. Drugs Ther., 3, 797-813 https://doi.org/10.1007/BF01869563
  15. Teng, C.M., Ko, F. N., 1988. Comparison of the platelet aeeresation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb. Haemost., 59, 304-9